Pulmonx Shares Outstanding History (LUNG)
Pulmonx reported 41.7M shares outstanding at the end of fiscal 2025.
View full Pulmonx company overviewPulmonx annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 41.7M | 1.9M | +4.74% |
| 2024 | 2024-12-31 | 39.8M | 1.3M | +3.30% |
| 2023 | 2023-12-31 | 38.5M | 960,818 | +2.56% |
| 2022 | 2022-12-31 | 37.6M | 623,803 | +1.69% |
| 2021 | 2021-12-31 | 36.9M | 1.2M | +3.47% |
| 2020 | 2020-12-31 | 35.7M | 33.6M | +1599.54% |
| 2019 | 2019-12-31 | 2.1M | — | — |
Pulmonx quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 42.9M | 2.2M | +5.41% |
| Q1 2026 | 2026-03-31 | 42.2M | 2.0M | +4.94% |
| Q4 2025 | 2025-12-31 | 41.7M | 1.9M | +4.74% |
| Q3 2025 | 2025-09-30 | 41.2M | 1.8M | +4.45% |
| Q2 2025 | 2025-06-30 | 40.7M | 1.6M | +4.07% |
| Q1 2025 | 2025-03-31 | 40.2M | 1.4M | +3.70% |
| Q4 2024 | 2024-12-31 | 39.8M | 1.3M | +3.30% |
| Q3 2024 | 2024-09-30 | 39.5M | 1.2M | +3.10% |
| Q2 2024 | 2024-06-30 | 39.2M | 1.1M | +2.99% |
| Q1 2024 | 2024-03-31 | 38.8M | 1.1M | +2.87% |
| Q4 2023 | 2023-12-31 | 38.5M | 960,818 | +2.56% |
| Q3 2023 | 2023-09-30 | 38.3M | 893,418 | +2.39% |
| Q2 2023 | 2023-06-30 | 38.0M | 750,641 | +2.01% |
| Q1 2023 | 2023-03-31 | 37.7M | 632,255 | +1.70% |
| Q4 2022 | 2022-12-31 | 37.6M | 623,803 | +1.69% |
| Q3 2022 | 2022-09-30 | 37.4M | 587,621 | +1.60% |
| Q2 2022 | 2022-06-30 | 37.3M | 685,413 | +1.87% |
| Q1 2022 | 2022-03-31 | 37.1M | 1.3M | +3.62% |
| Q4 2021 | 2021-12-31 | 36.9M | 1.2M | +3.47% |
| Q3 2021 | 2021-09-30 | 36.8M | 33.0M | +868.49% |
| Q2 2021 | 2021-06-30 | 36.6M | 34.5M | +1641.77% |
| Q1 2021 | 2021-03-31 | 35.8M | — | — |
| Q4 2020 | 2020-12-31 | 35.7M | — | — |
| Q3 2020 | 2020-09-30 | 3.8M | — | — |
| Q4 2019 | 2019-12-31 | 2.1M | — | — |
Pulmonx shares outstanding trends
Over the last five reported fiscal years, Pulmonx's shares outstanding moved from 35.7M to 41.7M, a change of 6.0M. The latest reported quarter, Q2 2026, shows 42.9M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pulmonx filings at SEC.gov ↗